Frequency of Usher syndrome in two pediatric populations: Implications for genetic screening of deaf and hard of hearing children, Genet Med, vol.12, pp.512-516, 2010. ,
An update on the genetics of usher syndrome, J Ophthalmol, p.417217, 2011. ,
Genetics and pathological mechanisms of Usher syndrome, J Hum Genet, vol.55, pp.327-335, 2010. ,
Expressivity of hearing loss in cases with Usher syndrome type IIA, Int J Audiol, vol.52, pp.832-837, 2013. ,
Retinitis pigmentosa, Lancet, vol.368, pp.1795-1809, 2006. ,
Comprehensive screening of the USH2A gene in Usher syndrome type II and nonsyndromic recessive retinitis pigmentosa, Exp Eye Res, vol.79, pp.167-173, 2004. ,
Novel mutations in the long isoform of the USH2A gene in patients with Usher syndrome type II or non-syndromic retinitis pigmentosa, J Med Genet, vol.47, pp.499-506, 2010. ,
Clinical aspects of Usher syndrome and the USH2A gene in a cohort of 433 patients, JAMA Ophthalmol, vol.133, pp.157-164, 2015. ,
Disease course in patients with autosomal recessive retinitis pigmentosa due to the USH2A gene, Invest Ophthalmol Vis Sci, vol.49, pp.5532-5539, 2008. ,
Visual prognosis in USH2A-associated retinitis pigmentosa is worse for patients with Usher syndrome type IIa than for those with nonsyndromic Retinitis Pigmentosa, Ophthalmology, vol.123, pp.1151-1160, 2016. ,
, , 2007.
, Lentiviral gene replacement therapy of retinas in a mouse model for Usher syndrome type 1B, Gene Ther, vol.14, pp.584-594
Retinal gene therapy with a large MYO7A cDNA using adeno-associated virus, Gene Ther, vol.20, pp.824-833, 2013. ,
Efficient gene delivery to the cone-enriched pig retina by dual AAV vectors, Gene Ther, vol.21, pp.450-456, 2014. ,
EIAVbased retinal gene therapy in the shaker1 mouse model for usher syndrome type 1B: development of UshStat, PLoS One, vol.9, p.94272, 2014. ,
Effect of gene therapy on visual function in Leber's congenital amaurosis, N Engl J Med, vol.358, pp.2231-2239, 2008. ,
Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics, Proceed Natl Acad Sci, vol.105, pp.15112-15117, 2008. ,
Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial, Hum Gene Ther, vol.19, pp.979-990, 2008. ,
Safety and efficacy of gene transfer for Leber's congenital amaurosis, N Engl J Med, vol.358, pp.2240-2248, 2008. ,
Advances in therapeutic CRISPR/Cas9 genome editing, Transl Res, vol.168, pp.15-21, 2016. ,
Four-year follow-up of diagnostic service in USH1 patients, Invest Ophthalmol Vis Sci, vol.52, pp.4063-4071, 2011. ,
Enrichment of LOVD-USHbases with 152 USH2A genotypes defines an extensive mutational spectrum and highlights missense hotspots, Hum Mutat, vol.35, pp.1179-1186, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-02433818
The USH2A c.2299delG mutation: dating its common origin in a Southern European population, Eur J Hum Genet, vol.18, pp.788-793, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-00509048
USH2A mutation analysis in 70 Dutch families with Usher syndrome type II, Hum Mutat, vol.24, p.185, 2004. ,
Usher syndrome type 2 caused by activation of an USH2A pseudoexon: implications for diagnosis and therapy, Hum Mutat, vol.33, pp.104-108, 2012. ,
Whole USH2A gene sequencing identifies several new deep intronic mutations, Hum Mutat, vol.37, pp.184-193, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01885918
Patient-specific iPSC-derived photoreceptor precursor cells as a means to investigate retinitis pigmentosa, vol.2, p.824, 2013. ,
Screening for duplications, deletions and a common intronic mutation detects 35% of second mutations in patients with USH2A monoallelic mutations on Sanger sequencing, Orphanet J Rare Dis, vol.8, p.122, 2013. ,
URL : https://hal.archives-ouvertes.fr/inserm-00851699
Screening for single nucleotide variants, small indels and exon deletions with a next-generation sequencing based gene panel approach for Usher syndrome, Mol Genet Genomic Med, vol.2, pp.393-401, 2014. ,
Targeted next generation sequencing for molecular diagnosis of Usher syndrome, Orphanet J Rare Dis, vol.9, p.168, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-02436412
MYO7A and USH2A gene sequence variants in Italian patients with Usher syndrome, Mol Vis, vol.20, pp.1717-1731, 2014. ,
Antisense oligonucleotide (AON)-based therapy for Leber congenital amaurosis caused by a frequent mutation in CEP290, Mol Ther Nucleic Acids, vol.1, p.14, 2012. ,
Exonic sequences provide better targets for antisense oligonucleotides than splice site sequences in the modulation of Duchenne muscular dystrophy splicing, Oligonucleotides, vol.20, pp.69-77, 2010. ,
Overview on AON design, Methods Mol Biol, vol.867, pp.117-129, 2012. ,
Transcriptional expression of cis-acting and trans-acting splicing mutations cause autosomal dominant retinitis pigmentosa, Hum Mutat, vol.29, pp.869-878, 2008. ,
Genetic therapies for RNA mis-splicing diseases, Trends Genet, vol.27, pp.196-205, 2011. ,
Splicing in disease: disruption of the splicing code and the decoding machinery, Nat Rev Genet, vol.8, pp.749-761, 2007. ,
Guidelines for antisense oligonucleotide design and insight into splice-modulating mechanisms, Mol Ther, vol.17, pp.548-553, 2009. ,
Exon-skipping antisense oligonucleotides to correct missplicing in neurogenetic diseases, Nucleic Acid Ther, vol.24, pp.69-86, 2014. ,
Antisense Oligonucleotide Therapy for Inherited Retinal Dystrophies, Adv Exp Med Biol, vol.854, pp.517-524, 2016. ,
Correction of a Cystic Fibrosis Splicing Mutation by Antisense Oligonucleotides, Hum Mutat, vol.37, pp.209-215, 2016. ,
Bifunctional antisense oligonucleotides provide a trans-acting splicing enhancer that stimulates SMN2 gene expression in patient fibroblasts, Proceed Natl Acad Sci, vol.100, pp.4114-4119, 2003. ,
Reversal of the cellular phenotype in the premature aging disease Hutchinson-Gilford progeria syndrome, Nat Med, vol.11, pp.440-445, 2005. ,
Restoration of the dystrophin-associated glycoprotein complex after exon skipping therapy in Duchenne muscular dystrophy, Mol Ther, vol.20, pp.462-467, 2012. ,
Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model, Genes Dev, vol.24, pp.1634-1644, 2010. ,
Intravitreal injection of splice-switching oligonucleotides to manipulate splicing in retinal cells, Mol Ther Nucleic Acids, vol.4, p.250, 2015. ,
In vitro and in vivo rescue of aberrant splicing in CEP290-associated LCA by antisense oligonucleotide delivery, Hum Mol Genet, 2016. ,
, , 2012.
, AON-mediated exon skipping restores ciliation in fibroblasts harboring the common Leber congenital amaurosis CEP290 mutation, Mol Ther Nucleic Acids, vol.1, p.29
Identification and correction of mechanisms underlying inherited blindness in human iPSCderived optic cups, Cell Stem Cell, vol.18, pp.769-781, 2016. ,
An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study, Lancet Neurol, vol.12, pp.435-442, 2013. ,
Clinical trials using antisense oligonucleotides in duchenne muscular dystrophy, Hum Gene Ther, vol.24, pp.479-488, 2013. ,
Systemic administration of PRO051 in Duchenne's muscular dystrophy, N Engl J Med, vol.364, pp.1513-1522, 2011. ,
Safety and efficacy of drisapersen for the treatment of Duchenne muscular dystrophy (DEMAND II): an exploratory, randomised, placebo-controlled phase 2 study, Lancet Neurol, vol.13, pp.987-996, 2014. ,
Pharmacokinetics and safety of single doses of drisapersen in non-ambulant subjects with Duchenne muscular dystrophy: results of a double-blind randomized clinical trial, Neuromuscul Disord, vol.24, pp.16-24, 2014. ,
Toll-like receptors and the eye, Invest Ophthalmol Vis Sci, vol.47, pp.1255-1263, 2006. ,
Innate immunity in the retina: Toll-like receptor (TLR) signaling in human retinal pigment epithelial cells, J Neuroimmunol, vol.153, pp.7-15, 2004. ,
Stimulation of the immune system by therapeutic antisense oligodeoxynucleotides and small interfering RNAs via nucleic acid receptors, Ann N Y Acad Sci, vol.1175, pp.40-54, 2009. ,
Exon skipping therapy for Duchenne muscular dystrophy, Adv Drug Deliv Rev, vol.87, pp.104-107, 2015. ,
Exploring the frontiers of therapeutic exon skipping for Duchenne muscular dystrophy by double targeting within one or multiple exons, Mol Ther, vol.14, pp.401-407, 2006. ,
, , 2007.
, Antisense oligonucleotide induced exon skipping and the dystrophin gene transcript: cocktails and chemistries, BMC Mol Biol, vol.8, p.57
, , 2007.
, Antisense oligonucleotide-induced exon skipping across the human dystrophin gene transcript, Mol Ther, vol.15, pp.1288-1296
Usherin is required for maintenance of retinal photoreceptors and normal development of cochlear hair cells, Proceed Natl Acad Sci, vol.104, pp.4413-4418, 2007. ,
The pros and cons of vertebrate animal models for functional and therapeutic research on inherited retinal dystrophies, Prog Retin Eye Res, vol.48, pp.137-159, 2015. ,
myosin 7aa(-/-) mutant zebrafish show mild photoreceptor degeneration and reduced electroretinographic responses, Exp Eye Res, vol.122, pp.65-76, 2014. ,
Harmonin (Ush1c) is required in zebrafish Müller glial cells for photoreceptor synaptic development and function, Dis Model Mech, vol.4, pp.786-800, 2011. ,
Duplicated genes with split functions: independent roles of protocadherin15 orthologues in zebrafish hearing and vision, Development, vol.132, pp.615-623, 2005. ,
PDZD7 is a modifier of retinal disease and a contributor to digenic Usher syndrome, J Clin Invest, vol.120, pp.1812-1823, 2010. ,
Species-dependent splice recognition of a cryptic exon resulting from a recurrent intronic CEP290 mutation that causes congenital blindness, Int J Mol Sci, vol.16, pp.5285-5298, 2015. ,
Periocular routes for retinal drug delivery, Expert Opin Drug Deliv, vol.1, pp.99-114, 2004. ,
Novel approaches to retinal drug delivery, Expert Opin Drug Deliv, vol.4, pp.371-388, 2007. ,
Nanoparticle delivery of antisense oligonucleotides and their application in the exon skipping strategy for Duchenne muscular dystrophy, Nucleic Acid Ther, vol.24, pp.87-100, 2014. ,
Aib-containing peptide analogs: cellular uptake and utilization in oligonucleotide delivery, Bioorg Med Chem, vol.22, pp.6776-6780, 2014. ,
Rescue of cardiomyopathy through U7snRNA-mediated exon skipping in Mybpc3-targeted knock-in mice, EMBO Mol Med, vol.5, pp.1128-1145, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-01549077
Restoration of full-length SMN promoted by adenoviral vectors expressing RNA antisense oligonucleotides embedded in U7 snRNAs, PLoS One, vol.4, p.8204, 2009. ,
Rescue of dystrophic muscle through U7 snRNA-mediated exon skipping, Science, vol.306, pp.1796-1799, 2004. ,
Inner limiting membrane barriers to AAV-mediated retinal transduction from the vitreous, Mol Ther, vol.17, pp.2096-2102, 2009. ,
Antibody neutralization poses a barrier to intravitreal adeno-associated viral vector gene delivery to non-human primates, Gene Ther, vol.22, pp.116-126, 2015. ,
Intraocular route of AAV2 vector administration defines humoral immune response and therapeutic potential, Mol Vis, vol.14, pp.1760-1769, 2008. ,
In vivo-directed evolution of a new adeno-associated virus for therapeutic outer retinal gene delivery from the vitreous, Sci Transl Med, vol.5, pp.189-76, 2013. ,
Usher syndrome: molecular links of pathogenesis, proteins and pathways, Hum Mol Genet, vol.15, issue.2, pp.262-270, 2006. ,
Scaffold protein harmonin (USH1C) provides molecular links between Usher syndrome type 1 and type 2, Hum Mol Genet, vol.14, pp.3933-3943, 2005. ,
Rescue of hearing and vestibular function by antisense oligonucleotides in a mouse model of human deafness, Nat Med, vol.19, pp.345-350, 2013. ,
RNAstructure: software for RNA secondary structure prediction and analysis, BMC Bioinformatics, vol.11, p.129, 2010. ,
Mutations in OTOGL, encoding the inner ear protein otogelin-like, cause moderate sensorineural hearing loss, Am J Hum Genet, vol.91, pp.872-882, 2012. ,